Trinidad and Tobago vs Tunisia: Hepatitis B surface antigen (HBsAg) prevalence
Trinidad and Tobago
0.1%
in 2024
Tunisia
0.1%
in 2024
Trinidad and Tobago rank
101st
Tunisia rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Trinidad and Tobago
- Tunisia
How they compare
Trinidad and Tobago currently reports 0.1% against 0.1% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Tunisia ahead.
Trinidad and Tobago ranks 101st and Tunisia ranks 101st of 194 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.0% | Trinidad and Tobago |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Trinidad and Tobago or Tunisia?
- Trinidad and Tobago, at 0.1% against 0.1% in Tunisia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Trinidad and Tobago and Tunisia?
- 0.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and Tunisia?
- 10 years are reported by both, from 2015 to 2024.
- How do Trinidad and Tobago and Tunisia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Trinidad and Tobago ranks 101st and Tunisia ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.